Historical Valuation
Oscar Health Inc (OSCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.31 is considered Undervalued compared with the five-year average of 24.75. The fair price of Oscar Health Inc (OSCR) is between 19.07 to 23.64 according to relative valuation methord. Compared to the current price of 17.73 USD , Oscar Health Inc is Undervalued By 7.03%.
Relative Value
Fair Zone
19.07-23.64
Current Price：17.73
7.03%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Oscar Health Inc (OSCR) has a current Price-to-Book (P/B) ratio of 3.82. Compared to its 3-year average P/B ratio of 3.02 , the current P/B ratio is approximately 26.48% higher. Relative to its 5-year average P/B ratio of 2.38, the current P/B ratio is about 60.46% higher. Oscar Health Inc (OSCR) has a Forward Free Cash Flow (FCF) yield of approximately 18.59%. Compared to its 3-year average FCF yield of 11.89%, the current FCF yield is approximately 56.37% lower. Relative to its 5-year average FCF yield of 10.33% , the current FCF yield is about 80.00% lower.
P/B
Median3y
3.02
Median5y
2.38
FCF Yield
Median3y
11.89
Median5y
10.33
Competitors Valuation Multiple
AI Analysis for OSCR
The average P/S ratio for OSCR competitors is 0.42, providing a benchmark for relative valuation. Oscar Health Inc Corp (OSCR.N) exhibits a P/S ratio of 0.31, which is -26.41% above the industry average. Given its robust revenue growth of 23.21%, this premium appears sustainable.
Performance Decomposition
AI Analysis for OSCR
1Y
3Y
5Y
Market capitalization of OSCR increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of OSCR in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is OSCR currently overvalued or undervalued?
Oscar Health Inc (OSCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.31 is considered Undervalued compared with the five-year average of 24.75. The fair price of Oscar Health Inc (OSCR) is between 19.07 to 23.64 according to relative valuation methord. Compared to the current price of 17.73 USD , Oscar Health Inc is Undervalued By 7.03% .
What is Oscar Health Inc (OSCR) fair value?
OSCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Oscar Health Inc (OSCR) is between 19.07 to 23.64 according to relative valuation methord.
How does OSCR's valuation metrics compare to the industry average?
The average P/S ratio for OSCR's competitors is 0.42, providing a benchmark for relative valuation. Oscar Health Inc Corp (OSCR) exhibits a P/S ratio of 0.31, which is -26.41% above the industry average. Given its robust revenue growth of 23.21%, this premium appears sustainable.
What is the current P/B ratio for Oscar Health Inc (OSCR) as of Jan 09 2026?
As of Jan 09 2026, Oscar Health Inc (OSCR) has a P/B ratio of 3.82. This indicates that the market values OSCR at 3.82 times its book value.
What is the current FCF Yield for Oscar Health Inc (OSCR) as of Jan 09 2026?
As of Jan 09 2026, Oscar Health Inc (OSCR) has a FCF Yield of 18.59%. This means that for every dollar of Oscar Health Inc’s market capitalization, the company generates 18.59 cents in free cash flow.
What is the current Forward P/E ratio for Oscar Health Inc (OSCR) as of Jan 09 2026?
As of Jan 09 2026, Oscar Health Inc (OSCR) has a Forward P/E ratio of -27.44. This means the market is willing to pay $-27.44 for every dollar of Oscar Health Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Oscar Health Inc (OSCR) as of Jan 09 2026?
As of Jan 09 2026, Oscar Health Inc (OSCR) has a Forward P/S ratio of 0.31. This means the market is valuing OSCR at $0.31 for every dollar of expected revenue over the next 12 months.